Zegna H1 Profit Drops 41% on Put Option Charge, But Adjusted EBIT Rises 8%
ZGN sits 56% above its 52-week low of $8.23.
Summary
Zegna's H1 2026 results show a sharp divergence between reported profit and underlying operating performance. Profit fell 41% to €28.4 million, dragged down by a non-cash remeasurement of Thom Browne put option liabilities, but Adjusted EBIT rose 8.4% to €74.5 million with margin up 10bps to 7.5%, beating estimates on DTC growth. Revenue grew 6.4% reported and 9.3% organic, with DTC up 15.8% organic and now 86% of branded sales. The balance sheet strengthened: net cash surplus improved to €59.6 million and free cash flow swung to positive €19.2 million from negative €23.1 million a year ago. This follows the Q2 revenue beat in July, confirming accelerating momentum in the core Zegna brand (13.9% organic growth) while Thom Browne remains a drag with negative adjusted EBIT. The market will focus on the margin expansion and cash generation, which validate the DTC-led strategy despite the headline profit decline.
At the time of this announcement, ZGN was trading at $12.85 on NYSE in the Trade & Services sector, with a market capitalization of approximately $5.3B. The 52-week trading range was $8.23 to $15.95. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: BusinessWire.